_version_ 1785146774580625408
author de Boer, Janneke W.
Pennings, Elise R. A.
Kleinjan, Ankie
van Doesum, Jaap A.
Spanjaart, Anne M.
Mutsaers, Pim G. N. J.
Jak, Margot
van der Poel, Marjolein W. M.
Kuipers, Maria T.
Adam, Judit A.
Diepstra, Arjan
Koens, Lianne
van Dorp, Suzanne
Vermaat, Joost S. P.
Niezink, Anne G. H.
Kersten, Marie José
van Meerten, Tom
author_facet de Boer, Janneke W.
Pennings, Elise R. A.
Kleinjan, Ankie
van Doesum, Jaap A.
Spanjaart, Anne M.
Mutsaers, Pim G. N. J.
Jak, Margot
van der Poel, Marjolein W. M.
Kuipers, Maria T.
Adam, Judit A.
Diepstra, Arjan
Koens, Lianne
van Dorp, Suzanne
Vermaat, Joost S. P.
Niezink, Anne G. H.
Kersten, Marie José
van Meerten, Tom
author_sort de Boer, Janneke W.
collection PubMed
description
format Online
Article
Text
id pubmed-10641469
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-106414692023-11-14 Inflammatory reactions mimic residual or recurrent lymphoma on [(18)F]FDG-PET/CT after CD19-directed CAR T-cell therapy de Boer, Janneke W. Pennings, Elise R. A. Kleinjan, Ankie van Doesum, Jaap A. Spanjaart, Anne M. Mutsaers, Pim G. N. J. Jak, Margot van der Poel, Marjolein W. M. Kuipers, Maria T. Adam, Judit A. Diepstra, Arjan Koens, Lianne van Dorp, Suzanne Vermaat, Joost S. P. Niezink, Anne G. H. Kersten, Marie José van Meerten, Tom Blood Adv Research Letter The American Society of Hematology 2023-08-30 /pmc/articles/PMC10641469/ /pubmed/37639324 http://dx.doi.org/10.1182/bloodadvances.2023010665 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
de Boer, Janneke W.
Pennings, Elise R. A.
Kleinjan, Ankie
van Doesum, Jaap A.
Spanjaart, Anne M.
Mutsaers, Pim G. N. J.
Jak, Margot
van der Poel, Marjolein W. M.
Kuipers, Maria T.
Adam, Judit A.
Diepstra, Arjan
Koens, Lianne
van Dorp, Suzanne
Vermaat, Joost S. P.
Niezink, Anne G. H.
Kersten, Marie José
van Meerten, Tom
Inflammatory reactions mimic residual or recurrent lymphoma on [(18)F]FDG-PET/CT after CD19-directed CAR T-cell therapy
title Inflammatory reactions mimic residual or recurrent lymphoma on [(18)F]FDG-PET/CT after CD19-directed CAR T-cell therapy
title_full Inflammatory reactions mimic residual or recurrent lymphoma on [(18)F]FDG-PET/CT after CD19-directed CAR T-cell therapy
title_fullStr Inflammatory reactions mimic residual or recurrent lymphoma on [(18)F]FDG-PET/CT after CD19-directed CAR T-cell therapy
title_full_unstemmed Inflammatory reactions mimic residual or recurrent lymphoma on [(18)F]FDG-PET/CT after CD19-directed CAR T-cell therapy
title_short Inflammatory reactions mimic residual or recurrent lymphoma on [(18)F]FDG-PET/CT after CD19-directed CAR T-cell therapy
title_sort inflammatory reactions mimic residual or recurrent lymphoma on [(18)f]fdg-pet/ct after cd19-directed car t-cell therapy
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641469/
https://www.ncbi.nlm.nih.gov/pubmed/37639324
http://dx.doi.org/10.1182/bloodadvances.2023010665
work_keys_str_mv AT deboerjannekew inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT penningselisera inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT kleinjanankie inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT vandoesumjaapa inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT spanjaartannem inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT mutsaerspimgnj inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT jakmargot inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT vanderpoelmarjoleinwm inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT kuipersmariat inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT adamjudita inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT diepstraarjan inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT koenslianne inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT vandorpsuzanne inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT vermaatjoostsp inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT niezinkannegh inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT kerstenmariejose inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy
AT vanmeertentom inflammatoryreactionsmimicresidualorrecurrentlymphomaon18ffdgpetctaftercd19directedcartcelltherapy